NOBIVAC® PUPPY DP

For the active immunisation of young puppies against canine distemper and canine parvovirus disease.

NOBIVAC® PUPPY DP

Reg. No. G2323 (Act 36/1947)

Namibia Reg. No. V97/24.1/888 [NS2]

Lyophilisate and solvent for suspension for injection

Only for use by or under the supervision of persons registered in terms of, or authorised in terms of, Section 23 (1) (c) of the Veterinary and Para-Veterinary Professions Act, 1982 (Act 19 of 1982).

INDICATIONS

For the active immunisation of young puppies against canine distemper and canine parvovirus disease.

COMPOSITION

It is a combination of live attenuated strains of canine distemper virus and canine parvovirus grown in cell-line tissue culture and presented as a freeze-dried plug.

CONTENTS

Each vial contains canine distemper virus, strain Onderstepoort ≥ 105 TCID50 and canine parvovirus, strain 154 ≥ 107 TCID50. Each vial contains a single dose for reconstitution.

TARGET SPECIES

Dogs

STORAGE INSTRUCTIONS

  • Store between 2 °C  – 8 °C in a refrigerator.
  • Do not freeze.
  • Protect from light.
  • Avoid prolonged or repetitive exposure to high ambient temperatures.
  • Allow the vaccine to gradually reach room temperature (20 °C to 25 °C) prior to use.
  • The diluent may be stored at room temperature.
  • After reconstitution use within 30 minutes.

WARNINGS

  • Vaccinate healthy dogs and puppies only. An adequate clinical examination should be made prior to vaccination.
  • Do not store partially used containers for future use, and use the entire contents when opened.
  • Nobivac® Puppy DP should be reconstituted using Nobivac® Diluent immediately prior to use.
  • In case of accidental self-injection may lead to severe allergic reactions. Seek medical advice immediately and show the package leaflet to the physician.
  • KEEP OUT OF REACH OF CHILDREN, UNINFORMED PERSONS AND ANIMALS.
  • Although this remedy has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder.

PRECAUTIONS

  • Observe aseptic precautions. Ensure that all vaccination equipment (containers, syringes and needles) is clean and sterile prior to and during use. Use sterile equipment when administering the vaccine.
  • Avoid contamination of the vaccine with traces of disinfectant and spirits.
  • Avoid intravenous injection.
  • Hypersensitivity reactions, following administration are rare but as with all vaccines it may occasionally be encountered. In this event administration of adrenaline injection by the subcutaneous route may be indicated.
  • It is good vaccination practice when handling the vaccine to avoid contact with the eyes, hands and clothing.
  • Destroy any unused vaccine and dispose of all the empty vaccine containers and disposable equipment after use in accordance with National Environmental Management: Waste Act, 2008 (Act No. 59 of 2008).
  • Do not contaminate rivers, dams or any water sources with containers or waste.

DIRECTIONS FOR USE – USE ONLY AS DIRECTED

  • Puppies should be vaccinated with a single dose of Nobivac® Puppy DP at 4 to 6 weeks of age, preferably before weaning.
  • Puppies which have received Nobivac® Puppy DP should be further immunised with Nobivac® DHPPi, 3 to 4 weeks later.

DOSAGE AND ADMINISTRATION

The contents of 1 vial of reconstituted vaccine should be injected subcutaneously.

Reconstitute immediately prior to use by the addition of the contents of 1 vial (1,0 mℓ) of Nobivac® Diluent. The vaccine should be administered by subcutaneous injection in the neck or chest region, observing the usual aseptic precautions.

PRESENTATION

Polyethylene terephthalate (PET) tray containing 10 single dose vials of freeze-dried vaccine.

REGISTRATION HOLDER                                   

Intervet South Africa (Pty) Ltd.                              

20 Spartan Road, Spartan,                                      

1619, RSA                                                              

Tel: +27 (0) 11 923 9300

E-mail: msdahza@msd.com

www.msd-animal-health.co.za

DATE OF PUBLICATION OF THIS PACKAGE INSERT

20 August 2013

Zimbabwe Reg. No. E97/80.23.15/9465
Pharmaceutical Classification: 802315
Distribution Category: V.M.G.D.